Adjunct Senior Research Fellow, Institute for Molecular Bioscience
Affiliate Professor, Queensland Brain Institute, The University of Queensland
On May 12, 2021, Jake Gratten and Naomi Wray will present findings from the Australian Autism Biobank study, an initiative to establish an Australian resource of biospecimens, phenotypes and genomic data for autism research.
Small molecules, genes and antisense oligonucleotides: Industry perspectives on treatment development for ASD
Vice President, Head of Clinical Science, Axial Therapeutics
Stuart Cobb, Ph.D.
Chief Scientific Officer, Neurogene; Research Fellow, University of Edinburgh
Yael Weiss, M.D., Ph.D.
Vice President, Business Development, Ultragenyx
Randy Carpenter, M.D.
Chief Medical Officer, Rett Syndrome Research Trust; Co-Founder, Allos Pharma
On May 14, 2021, Federico Bolognani, Stuart Cobb, and Yael Weiss will join a panel to discuss new industry developments on the use of small molecules, gene therapy and antisense oligonucleotides as treatment approaches for autism spectrum disorders (ASD). The panel discussion will be moderated by Randall Carpenter.
On May 20, 2021, the SFARI science team will hold an informational session to answer questions about the 2021 Genomics of ASD: Pathways to Genetic Therapies request for applications.
Chief Clinical Officer, Dascena
Joseph Buxbaum, Ph.D.
Director, Seaver Autism Center
Professor, Psychiatry, Neuroscience, Genetics and Genomic Sciences
Vice Chair for Research and Vice Chair for Mentoring, Psychiatry, Icahn School of Medicine at Mount Sinai
Heather Mefford, M.D., Ph.D.
Full Member, St. Jude Children’s Research Hospital
On May 21, 2021, David Ledbetter and Joseph Buxbaum will discuss whether there are genes for which mutations confer risk specific to autism or whether these genes are really conferring general risk of disrupted brain development. The discussion will be moderated by Heather Mefford.
On 26 March 2014, Ami Klin presented two new infant and toddler behavioral measures of social behaviors.
Scientific Director, Autism BrainNet
On 26 February 2014, David Amaral discussed different types of altered brain development among children with autism.
On 6 November 2013, Amanda Woodward discussed the nature and origins of children’s social understanding.
On 26 September 2013, Catherine Lord and Steven Hyman presented conceptual frameworks for autism and suggest avenues to advance the field.
On 30 May 2013, Betty Diamond discussed immune-system-mediated alterations in brain development.
On 25 April 2013, Matthew State discussed genetic discoveries in autism research and the challenges that lie ahead.